Everon Biosciences is planning a big showing at The Biology of Aging conference in Jupiter, Florida on January 22-25, 2017. In addition to the invited talk by Dr. Andrei Gudkov, our CSO, company’s scientific and technological achievements will be presented in 5 posters. Among notable results is the disclosure of Everon’s first drug candidate that could enter clinic within next 18 months. This is a proprietary small molecule that rejuvenates mice (as measured by a lowered Frailty Index) and prolongs their lives. Company’s vision of developing drugs that treat aging itself as a disease is turning from a futuristic dream to reality!
- Everon Biosciences Introduces Physiological Frailty Index as a Measure of Biological Age in Mice, Enhancing the Development of Healthspan-Extending Pharmaceuticals March 21, 2017
- Andrei Gudkov taped an expanded presentation of the slides he presented at 2017 Biology of Aging conference at Scripps, Florida, 22-27 January March 21, 2017
- Everon Biosciences Publishes a Study Suggesting a New Biomarker of Senescent Cells for Anti-Aging Research and Drug Development February 15, 2017